<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00863889</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00010776</org_study_id>
    <nct_id>NCT00863889</nct_id>
  </id_info>
  <brief_title>Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome</brief_title>
  <official_title>Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to conduct a randomized, single-blinded placebo controlled
      trial comparing two modalities for the treatment of pain and mobility associated with
      trochanteric bursitis: (1) injection of glucocorticosteroid and local anesthetic, (2)
      injection of local anesthetic. We hope to determine whether steroid injections provide a
      statistically significant improvement in pain symptoms and hip mobility in subjects with
      trochanteric bursitis, as compared to an injection of local anesthetic. Our null hypothesis
      is that no statistically significant difference exists between the two treatment modalities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trochanteric bursitis is an inflammation of the bursal sac overlying the greater trochanter
      of the femur. The etiology of this disease is unknown, but it is clinically characterized by
      chronic aching pain over the lateral aspect of the hip, which can be exacerbated by certain
      movements such as external rotation and abduction (2). In order to objectively determine the
      level of pain and mobility associated with trochanteric bursitis, some orthopaedic surgeons
      use scoring systems (a qualitative and quantitative scoring test) to assess patients (4).

      In our practice, trochanteric bursitis has been treated by injection of glucocorticosteroids
      (steroids) combined with local anesthetic at the site of the greater trochanter (1).
      Additionally, it has been found that increasing steroid dosage provides a greater level of
      relief (3). Although steroids are usually an effective treatment, no studies to date have
      compared steroid injections for relief of trochanteric bursitis pain and mobility versus a
      placebo injection or local anesthetic injection alone.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WOMAC hip score</measure>
    <time_frame>2 weeks, 6 weeks, 3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Bursitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1cc Depomedrol, 4 cc 1% Lidocaine, 4 cc 0.25% Marcaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4 cc 1% Lidocaine, 4 cc 0.25% Marcaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Depomedrol injection</intervention_name>
    <description>1 cc of Depomedrol 80</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine, Marcaine</intervention_name>
    <description>4 cc of each local anesthetic</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with tenderness at the greater trochanter

        Exclusion Criteria:

          -  Subjects &lt; 17 years of age

          -  Subjects with previous surgery to the greater trochanter

          -  Subjects allergic to Lidocaine, Marcaine, or Depomedrol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tom Bradbury, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Tom Bradbury</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.orthogate.org/patient-education/hip/trochanteric-bursitis-of-the-hip.html</url>
    <description>Patient education on Trochanteric Bursitis</description>
  </link>
  <reference>
    <citation>Shbeeb MI, O'Duffy JD, Michet CJ Jr, O'Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol. 1996 Dec;23(12):2104-6.</citation>
    <PMID>8970048</PMID>
  </reference>
  <reference>
    <citation>Silva F, Adams T, Feinstein J, Arroyo RA. Trochanteric bursitis: refuting the myth of inflammation. J Clin Rheumatol. 2008 Apr;14(2):82-6. doi: 10.1097/RHU.0b013e31816b4471.</citation>
    <PMID>18391676</PMID>
  </reference>
  <reference>
    <citation>Brinks A, van Rijn RM, Bohnen AM, Slee GL, Verhaar JA, Koes BW, Bierma-Zeinstra SM. Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice. BMC Musculoskelet Disord. 2007 Sep 19;8:95.</citation>
    <PMID>17880718</PMID>
  </reference>
  <reference>
    <citation>Baker CL Jr, Massie RV, Hurt WG, Savory CG. Arthroscopic bursectomy for recalcitrant trochanteric bursitis. Arthroscopy. 2007 Aug;23(8):827-32. Epub 2007 Jun 14.</citation>
    <PMID>17681203</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2009</study_first_posted>
  <last_update_submitted>September 19, 2013</last_update_submitted>
  <last_update_submitted_qc>September 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Thomas L Bradbury, MD</investigator_full_name>
    <investigator_title>Residency Program Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

